We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATCO
576
DELISTED
Atlas Corp.
ATCO
| $7.88M | 0.01% |
513,954
+418,536
| +439% | +$6.32M |
|
577
Transocean
RIG
$6.48B
| $7.86M | 0.01% |
1,722,922
-1,252,383
| -42% | -$4.83M |
|
578
Federated Hermes
FHI
$4.7B
| $7.83M | 0.01% |
215,603
+185,783
| +623% | +$6.52M |
|
579
Tenable Holdings
TENB
$4.17B
| $7.79M | 0.01% |
204,163
+11,999
| +6% | +$440K |
|
|
VSTO
580
DELISTED
Vista Outdoor Inc.
VSTO
| $7.75M | 0.01% |
318,087
-799,536
| -72% | -$21M |
|
581
Bio-Techne
TECH
$11.2B
| $7.75M | 0.01% |
93,451
-32,505
| -26% | -$2.58M |
|
582
Pilgrim's Pride
PPC
$6.4B
| $7.72M | 0.01% |
325,311
-812,790
| -71% | -$19.4M |
|
583
Neurocrine Biosciences
NBIX
$16.5B
| $7.67M | 0.01% |
64,226
-143,124
| -69% | -$16.8M |
|
584
Acco Brands
ACCO
$396M
| $7.66M | 0.01% |
1,369,406
+146,262
| +12% | +$760K |
|
585
Wabash National
WNC
$504M
| $7.65M | 0.01% |
+338,680
| New | +$7.35M |
|
586
Steris
STE
$23.2B
| $7.6M | 0.01% |
41,134
+2,053
| +5% | +$361K |
|
587
Meritage Homes
MTH
$4.81B
| $7.58M | 0.01% |
+164,410
| New | +$6.65M |
|
|
SKX
588
DELISTED
Skechers
SKX
| $7.55M | 0.01% |
180,028
-600,163
| -77% | -$23M |
|
589
Vontier
VNT
$4.61B
| $7.54M | 0.01% |
390,231
+352,636
| +938% | +$6.61M |
|
590
Quanex
NX
$1B
| $7.46M | 0.01% |
315,071
+9,857
| +3% | +$222K |
|
591
Las Vegas Sands
LVS
$29.6B
| $7.46M | 0.01% |
+155,157
| New | +$6.58M |
|
592
CAE Inc. Common Shares
CAE
$8.74B
| $7.43M | 0.01% |
+384,361
| New | +$7.39M |
|
593
Criteo S.A. Ordinary Shares
CRTO
$867M
| $7.35M | 0.01% |
282,142
+128,206
| +83% | +$3.32M |
|
594
Elanco Animal Health
ELAN
$11.4B
| $7.35M | 0.01% |
601,299
+260,171
| +76% | +$3.24M |
|
595
Harmony Gold Mining
HMY
$12.2B
| $7.33M | 0.01% |
+2,157,400
| New | +$6.8M |
|
596
Adient
ADNT
$1.48B
| $7.3M | 0.01% |
+210,400
| New | +$7.36M |
|
597
Zeta Global
ZETA
$7.32B
| $7.26M | 0.01% |
888,310
+219,811
| +33% | +$1.78M |
|
598
Haverty Furniture Companies
HVT
$444M
| $7.25M | 0.01% |
242,367
+97,550
| +67% | +$2.85M |
|
|
ABB
599
DELISTED
ABB Ltd
ABB
| $7.22M | 0.01% |
237,203
+17,524
| +8% | +$510K |
|
600
Copa Holdings
CPA
$5.49B
| $7.18M | 0.01% |
86,372
+45,195
| +110% | +$3.56M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.